MAP4K4 and atherosclerosis: Endothelial Map4k4 KD mice did not display altered plasma lipid levels (Supplementary Table 1); therefore, the reduction in plasma lipids that was observed in Ldlr−/− mice after PF-06260933 treatment could contribute to the reduced atherosclerosis in a manner that is independent of the endothelium.